Monday, December 19, 2016

Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits


By MATT RICHTEL and ANDREW POLLACK from NYT Health Harnessing the U.S. Taxpayer to Fight Cancer and Make Profits
Public funding is backing a new immunotherapy treatment, but the bulk of any profits will go to a private company. So are taxpayers getting a good deal? Read more article at hafana

No comments:

Post a Comment